{"id":16530,"date":"2023-05-11T08:41:28","date_gmt":"2023-05-11T08:41:28","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=16530"},"modified":"2025-08-19T16:14:15","modified_gmt":"2025-08-19T16:14:15","slug":"german-robert-janker-klinik-cancer-center-to-be-equipped-with-integrated-oncology-solutions-from-philips-and-elekta","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/german-robert-janker-klinik-cancer-center-to-be-equipped-with-integrated-oncology-solutions-from-philips-and-elekta\/","title":{"rendered":"German Robert Janker Klinik Cancer Center to be Equipped with Integrated Oncology Solutions from Philips and Elekta"},"content":{"rendered":"\n

Royal Philips<\/a>, Elekta<\/a>, and Mercurius Health announces the signing of a 3-year agreement under which Philips and Elekta will install state-of-the-art diagnostic and therapeutic oncology equipment and associated informatics solutions at Mercurius Health\u2019s newly-acquired Robert Janker Klinik cancer center in Bonn, Germany.<\/p>\n\n\n\n

The investment in Philips and Elekta solutions by Mercurius Health is part of its commitment to establishing a major presence in Germany, following the company\u2019s acquisition of Robert Janker Klinik earlier this year.<\/p>\n\n\n\n

The agreement has been enabled by the strategic partnership between Philips and Elekta to advance comprehensive personalized cancer care through the deployment of precision oncology solutions. The Robert Janker Klinik, a specialized hospital in oncology and palliative care, focuses on minimally invasive diagnostics and treatments for cancer. The hospital has three inpatient departments (radiology, radiotherapy and palliative care) and an outpatient unit for radiotherapy. It employs around 130 staff and treats patients from across the region as well as national and international patients.<\/p>\n\n\n\n

\u201cThis major investment in cutting-edge technology by Mercurius Health means many of the projects currently in planning can be rapidly moved forward, making us a showcase for what the future of cancer care will look like,\u201d said Prof. Dr. Attila Kov\u00e1cs, Head Physician of the Clinic for Diagnostic and Interventional Radiology and Neuroradiology.<\/p>\n\n\n\n

\n

The combination of Philips\u2019 diagnostic imaging and oncology informatics solutions, and Elekta\u2019s radiation therapy solutions means we will be able to offer our patients state-of-the-art therapy for tumors such as prostate and liver cancer that are currently difficult to treat, improving clinical outcomes.<\/p>\nProf. Dr. Michael Pinkawa, Radiation Oncologist and Head of Radiotherapy at Robert Janker Klinik<\/cite><\/blockquote>\n\n\n\n

To make a precise and informed diagnosis and select the optimal therapy for each individual cancer patient, oncologists often need to consider and scrutinize around 10,000 data points, many of which reside in disparate IT systems \u2013 electronic medical records, lab systems, radiology, pathology, and genomics. Philips and Elekta bring all this data together and translate it into actionable insights, and pathways with predictable outcomes for each patient.<\/p>\n\n\n\n

The combined solutions enable oncologists to deliver precise and personalized therapies that treat tumors effectively while sparing adjacent tissue and organs at risk. Installed in Robert Janker Klinik, they will provide Mercurius Health with a platform to showcase its consultancy and B2B oncology services in the German market and continue its pioneering work in increasing productivity, improving patient and staff experience, and enhancing clinical care.<\/p>\n","protected":false},"excerpt":{"rendered":"

The hospital will be equipped with state-of-the-art diagnostic and therapeutic oncology solutions over the next three years, contributing to enhanced patient care<\/p>\n","protected":false},"author":2,"featured_media":16531,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[488,681,6,10],"tags":[756,619,57],"class_list":["post-16530","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","category-care-therapy","category-europe","category-strategic-development","tag-cancers","tag-partnerships","tag-philips"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/16530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=16530"}],"version-history":[{"count":5,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/16530\/revisions"}],"predecessor-version":[{"id":34628,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/16530\/revisions\/34628"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/16531"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=16530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=16530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=16530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}